Final Report on a Placebo-Controlled, Double-Blind, Randomized, Multicentre Trial of Cyclosporin Treatment in Active Chronic Crohn's Disease

Scandinavian Journal of Gastroenterology ◽

10.3109/00365529108998585 ◽

1991 ◽

Vol 26 (7) ◽

pp. 689-695 ◽

Author(s):

J. Brynskov ◽

L. Freund ◽

S. Nørby Rasmussen ◽

K. Lauritsen ◽

O. Schaffalitzky De Muckadell ◽

...

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Multicentre Trial ◽

Final Report ◽

Double Blind ◽

Cyclosporin Treatment

Download Full-text

Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial

Yearbook of Gastroenterology ◽

10.1016/j.ygas.2010.12.001 ◽

2011 ◽

Vol 2011 ◽

pp. 147-148

Author(s):

M.F. Picco

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Multicentre Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Clinical Recurrence ◽

Endoscopic Recurrence

Download Full-text

P608 Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in Crohn's disease patients with endoscopic recurrence: follow-up data of a randomised, double-blind, double-dummy, 1-year, multicentre trial

Journal of Crohn s and Colitis ◽

10.1016/s1873-9946(13)60629-7 ◽

2013 ◽

Vol 7 ◽

pp. S254 ◽

Author(s):

W. Reinisch ◽

S. Angelberger ◽

W. Petritsch ◽

O. Shonova ◽

M. Lukas ◽

...

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Multicentre Trial ◽

Double Blind ◽

Clinical Recurrence ◽

Endoscopic Recurrence

Download Full-text

Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial

Gut ◽

10.1136/gut.2009.194159 ◽

2010 ◽

Vol 59 (6) ◽

pp. 752-759 ◽

Author(s):

W. Reinisch ◽

S. Angelberger ◽

W. Petritsch ◽

O. Shonova ◽

M. Lukas ◽

...

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Multicentre Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Clinical Recurrence ◽

Endoscopic Recurrence

Download Full-text

11 Vedolizumab induction therapy for patients with Crohn's disease and prior anti-tumour necrosis factor antagonist failure: a randomised, placebo-controlled, double-blind, multicentre trial

Journal of Crohn s and Colitis ◽

10.1016/s1873-9946(13)60012-4 ◽

2013 ◽

Vol 7 ◽

pp. S5-S6 ◽

Author(s):

B. Sands ◽

B. Feagan ◽

P. Rutgeerts ◽

J.-F. Colombel ◽

W. Sandborn ◽

...

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Tumour Necrosis Factor ◽

Induction Therapy ◽

Tumour Necrosis ◽

Multicentre Trial ◽

Double Blind ◽

Tumour Necrosis Factor Antagonist ◽

Factor Antagonist ◽

Necrosis Factor

Download Full-text

Discontinuation of infliximab therapy in patients with Crohn's disease in sustained complete remission (the STOP IT study): protocol for a double-blind, randomised, placebo-controlled, multicentre trial

BMJ Open ◽

10.1136/bmjopen-2014-005887 ◽

2014 ◽

Vol 4 (12) ◽

pp. e005887 ◽

Author(s):

Sine Schnoor Buhl ◽

Casper Steenholdt ◽

Jørn Brynskov ◽

Ole Østergaard Thomsen ◽

Klaus Bendtzen ◽

...

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Complete Remission ◽

Study Protocol ◽

Multicentre Trial ◽

Infliximab Therapy ◽

Download Full-text

Ornidazole for Prophylaxis of Postoperative Crohn's Disease Recurrence: A Randomized, Double-Blind, Placebo-Controlled Trial

Yearbook of Gastroenterology ◽

10.1016/s0739-5930(08)70327-1 ◽

2006 ◽

Vol 2006 ◽

pp. 117-118

Author(s):

G.R. Lichtenstein

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Controlled Trial ◽

Disease Recurrence ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of P087 - SONIC: a randomized, double-blind, controlled trial comparing infliximab and infliximab plus azathioprine to azathioprine in patients with Crohn’s disease naive to immunomodulators and biologic therapy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718140561.793485253 ◽

2013 ◽

Author(s):

Richard Pollok

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Biologic Therapy ◽

Controlled Trial ◽

Download Full-text

Mesalamine(M) in Crohn's disease (CD) patients with prednisolone-induced remission: Effect on steroid weaning and remission maintenance in the year after weaning: A placebo-controlled, multicentre double-blind trial

Gastroenterology ◽

10.1016/0016-5085(95)27817-6 ◽

1995 ◽

Vol 108 (4) ◽

pp. A878 ◽

Author(s):

R. Modigliani ◽

J.F. Colombel ◽

J.L. Dupas ◽

M. Dapoigny ◽

Y. Bouhnik ◽

...

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Double Blind Trial ◽

Double Blind ◽

Blind Trial ◽

Remission Maintenance

Download Full-text

OP025. A randomized, double-blind placebo-controlled phase 2a induction study of MEDI2070 (anti-p19 antibody) in patients with active Crohn's disease who have failed anti-TNF antibody therapy

Journal of Crohn s and Colitis ◽

10.1093/ecco-jcc/jju027.025 ◽

2015 ◽

Vol 9 (suppl 1) ◽

pp. S15-S16 ◽

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Antibody Therapy ◽

Double Blind ◽

Double Blind Placebo ◽

Induction Study

Download Full-text

5-Aminosalicylic Acid in the Treatment of Crohn's Disease: A 16-Week Double-Blind, Placebo-Controlled, Multicentre Study with Pentasa®

Scandinavian Journal of Gastroenterology ◽

10.3109/00365528708991929 ◽

1987 ◽

Vol 22 (7) ◽

pp. 877-883 ◽

Author(s):

S. N. Rasmussen ◽

K. Lauritsen ◽

U. Tage-Jensen ◽

O. H. Nielsen ◽

P. Bytzer ◽

...

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Multicentre Study ◽

Aminosalicylic Acid ◽

Double Blind ◽

Double Blind Placebo

Download Full-text